Trial intelligence / Profile preview

RTS,S/AS01B and ChAd63/MVA ME-TRAP in Malaria

NCT02252640Phase 2Completed

Sponsor
University of Oxford
Start
Jan 2015
Primary completion
Oct 2015
Modality
Viral Vector Vaccines, DNA Vaccines
Countries
1
01

Overview

A Phase 2 trial of RTS,S, ChAd63 ME-TRAP, MVA ME-TRAP in malaria, sponsored by University of Oxford. Started Jan 2015; status: completed.

02

Drugs

RTS,SChAd63 ME-TRAPMVA ME-TRAP
03

Conditions

malaria

Beyond the preview

Go deeper on NCT02252640.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02252640.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call